A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions.
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The study will determine the best drug (MAL or HAL) dosage for photodynamic therapy of
cervical precancerous lesions (dysplasia) in women that are referred for conisation
(surgery).